From firstname.lastname@example.org | Tuesday 3 December 2019
State-of-the-art facility is first milestone of a £200m investment programme in the city.
Hull firm RB has revealed its magnificent £105m science and innovation centre.
The firm, one of the world's leading consumer health, hygiene and home companies, opened the much-anticipated centre on Tuesday 3 December.
The state-of-the-art facility, with new consumer health laboratory facilities, is the first milestone of a £200m investment programme in the city.
A look inside RB’s £105m science and innovation centre. Picture: Karl Andre Photography
The firm, which has a 179-year history in Hull, is committing £95m to upgrade its manufacturing facilities on the Hull site, which employs 1,400.
The new facility will create 200 jobs and, it is hoped, will allow the firm to attract some of the world's best scientific talent.
Mark Jones, Hull City Council's director of regeneration, said: “The council welcomes this huge investment in the city, which will attract some of the most talented people from the scientific community to Hull. This centre, alongside others like it, proves that Hull really is a UK leader in research and development.
The formulation laboratory at RB’s £105m science and innovation centre.
"RB has a rich history in the city and the opening of this fantastic facility guarantees that this relationship will continue for many years to come.”
One of six major RB research and development facilities worldwide, it will be the global technical innovation hub for household names including Nurofen and Strepsils.
The reception area at RB’s £105m science and innovation centre.
The decision to build the centre in Hull followed a comprehensive review of the city alongside other locations across the globe.
The centre is RB’s largest healthcare development centre and the biggest single site investment in the company’s history.